Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Metabolites detected from human bronchoalveolar lavage (Study ST000346)

RP POSITIVE ION MODE (Analysis AN000561)

Metabolite	Structure	F1	F2	F3	F4
SM (d34:1)	ME119167	0.12	0.08	7.68	0.13
TG (52:2)	ME119177	0.05	0.15	7.69	0.12
TG (52:3)	ME119178	0.04	0.13	7.69	0.15
LPC (16:0)	ME119096	0.02	0.07	8.21	0.02
TG (52:4)	ME119179	0.03	0.09	7.94	0.10
LPC (18:0)	ME119097	0.05	0.13	7.94	0.04
LPC (18:1)	ME119098	0.04	0.11	8.01	0.05
TG (52:1)	ME119176	0.09	0.84	5.87	0.13
PC (35:4)	ME119120	0.35	0.71	5.14	0.28
PC (p-40:6) or PC (o-40:7) A	ME119155	0.41	0.60	5.31	0.26
PC (36:4) B	ME119126	0.34	0.67	5.27	0.29
PC (38:5) A	ME119135	0.33	0.64	5.31	0.31
SM (d42:1)	ME119173	0.30	0.53	5.77	0.26
PC (40:7)	ME119142	0.33	0.56	5.60	0.27
PC (p-34:2) or PC (o-34:3)	ME119150	0.43	0.50	5.57	0.24
SM (d36:1)	ME119169	0.17	0.27	6.92	0.20
PC (38:3)	ME119132	0.14	0.29	7.03	0.16
SM (d41:1)	ME119172	0.14	0.29	7.02	0.17
TG (56:7)	ME119180	0.10	0.21	7.13	0.23
SM (d42:3)	ME119175	0.12	0.27	7.16	0.14
PC (40:6) B	ME119141	0.14	0.25	7.19	0.14
SM (d34:2)	ME119168	0.16	0.24	7.16	0.14
PC (40:4)	ME119138	0.18	0.32	6.82	0.18
SM (d40:1)	ME119171	0.18	0.33	6.75	0.19
CE (20:4)	ME119094	0.09	0.42	6.58	0.26
PC (38:6) A	ME119137	0.21	0.38	6.58	0.18
SM (d38:1)	ME119170	0.20	0.38	6.54	0.19
SM (d42:2)	ME119174	0.19	0.33	6.67	0.21
SM (d32:1)	ME119163	0.22	0.35	6.64	0.17
SM (d33:1)	ME119164	0.19	0.37	6.66	0.17
PC (p-36:3) or PC (o-36:4)	ME119151	0.15	0.41	6.70	0.16
PC (p-38:3) or PC (o-38:4)	ME119153	0.15	0.43	6.63	0.18
PC (40:5) B	ME119140	0.24	0.43	6.36	0.18
PC (p-38:4) or PC (o-38:5) A	ME119154	0.20	0.43	6.43	0.19
PC (p-34:1) or PC (o-34:2) A	ME119148	0.25	0.45	6.24	0.20
CE (18:1)	ME119091	0.23	0.37	6.27	0.30
PC (40:5) A	ME119139	0.22	0.39	6.34	0.26
PC (p-36:4) or PC (o-36:5)	ME119152	0.19	0.44	6.30	0.25
PC (38:4) A	ME119133	0.26	0.47	6.02	0.26
CE (18:2)	ME119092	0.24	0.39	6.04	0.36
CE (18:3)	ME119093	0.24	0.35	6.15	0.34
SM (d34:0)	ME119165	0.25	0.34	6.14	0.35
Acylcarnitine C16:0	ME119089	0.65	1.58	1.75	0.47
Acylcarnitine C18:1	ME119090	0.58	1.65	1.81	0.45
PC (36:4) C	ME119127	0.79	1.25	1.65	0.70
PC (36:5) A	ME119128	0.89	1.39	1.71	0.44
PC (16:0/9:0(CHO))	ME119099	1.02	1.07	1.93	0.54
Cholesterol	ME119095	0.79	1.13	1.96	0.70
PC (35:1)	ME119116	0.76	1.33	1.91	0.54
PC (p-40:7) or PC (o-40:8)	ME119156	0.73	1.60	1.42	0.51
PC (34:3)	ME119113	1.03	1.42	1.34	0.42
PC (o-32:0)	ME119144	0.88	1.62	1.05	0.47
PC (32:2)	ME119106	0.94	1.45	1.22	0.52
PC (34:4)	ME119114	0.82	1.58	1.23	0.50
PE (36:1)	ME119158	0.98	1.50	0.54	0.70
PC (p-32:0) or PC (o-32:1)	ME119146	1.04	1.55	0.79	0.50
PE (34:2)	ME119157	0.91	1.52	0.93	0.60
PC (33:1)	ME119109	0.93	1.59	0.83	0.55
PC (o-34:0)	ME119145	0.87	1.62	0.76	0.61
PC (32:0)	ME119104	0.95	1.58	0.07	0.85
PC (28:0)	ME119100	0.97	1.76	0.10	0.64
PC (34:0)	ME119111	0.96	1.73	0.16	0.64
PC (30:0)	ME119101	1.07	1.68	0.04	0.63
PC (32:3)	ME119107	1.05	1.73	0.05	0.60
PC (30:1)	ME119102	1.06	1.73	0.15	0.55
PC (32:1)	ME119105	1.07	1.67	0.13	0.61
PC (31:0)	ME119103	1.07	1.83	0.04	0.48
PC (33:0)	ME119108	0.96	1.93	0.04	0.49
1_CUDA (pos) iSTD iSTD	ME119074	1.02	0.77	1.04	1.19
1_Sphingosine (d17:1) iSTD	ME119086	1.09	1.02	0.55	1.07
1_Ceramide C17 iSTD	ME119072	1.04	1.06	0.60	1.06
1_CE (22:1) iSTD	ME119069	1.05	1.02	0.65	1.07
1_MG (17:0/0:0/0:0) iSTD	ME119082	1.05	1.04	0.69	1.04
1_Cholesterol d7 iSTD	ME119073	1.13	0.93	0.31	1.22
1_DG (12:0/12:0/0:0) iSTD	ME119076	1.07	1.06	0.45	1.08
1_DG (18:1/2:0/0:0) iSTD	ME119078	1.07	1.06	0.47	1.09
1_LPC (17:0) iSTD	ME119079	1.04	1.07	0.44	1.11
1_LPE (17:1) iSTD	ME119080	1.05	1.09	0.42	1.10
1_PC (25:0) iSTD	ME119083	1.09	1.08	0.34	1.09
1_SM (d35:1) iSTD	ME119085	1.04	1.12	0.36	1.10
1_PE (17:0/17:0) iSTD	ME119084	1.01	1.03	0.38	1.21
1_TG (17:0/17:1/17:0)-d5 iSTD	ME119088	1.10	0.98	0.40	1.16
PC (35:2)	ME119118	0.71	1.31	2.29	0.47
PC (36:4) A	ME119125	0.76	1.23	2.43	0.43
PC (36:3) A	ME119123	0.79	1.13	2.34	0.54
PC (p-34:0) or PC (o-34:1)	ME119147	0.77	1.17	2.36	0.52
PC (36:1)	ME119121	0.66	1.04	3.07	0.47
PC (36:3) B	ME119124	0.66	1.04	3.22	0.40
PC (40:8)	ME119143	0.74	1.19	2.70	0.39
PE (p-36:4) or PE (o-36:5)	ME119160	0.60	1.05	2.81	0.63
PE (p-36:2) or PE (o-36:3)	ME119159	0.70	1.08	2.87	0.48
PC (34:2)	ME119112	0.69	1.08	2.77	0.51
PC (35:3)	ME119119	0.73	1.07	2.74	0.50
PC (33:2)	ME119110	0.68	0.99	3.51	0.33
PC (37:4)	ME119130	0.51	1.09	3.56	0.38
PE (p-38:4) or PE (o-38:5)	ME119161	0.49	0.99	3.64	0.46
PC (38:5) B	ME119136	0.41	0.79	4.80	0.28
PE (p-38:5) or PE (o-38:6)	ME119162	0.50	0.74	4.05	0.54
PC (36:5) B	ME119129	0.46	0.92	4.28	0.30
PC (36:2)	ME119122	0.52	0.81	4.26	0.37
PC (38:4) B	ME119134	0.52	0.87	4.26	0.32
PC (38:2)	ME119131	0.46	0.78	4.46	0.37
PC (p-34:1) or PC (o-34:2) B	ME119149	0.41	0.95	4.42	0.27

Factors:

F1	Condition:Mild Asthma
F2	Condition:No Asthma
F3	Condition:Quality Control
F4	Condition:Severe Asthma

Data matrix